Lobbying activity
Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 65 filings
Top spenders & firms Spend by issue Political contributions Revolving door
4T
CAPITOL HILL CONSULTING GROUP for ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY GENERIC PHARMACEUTICAL ASSOC.)
Q4
MEHLMAN CONSULTING, INC. for ASSOCIATION OF ACCESSIBLE MEDICINES
Q4
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Q4
FIERCE GOVERNMENT RELATIONS for ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA)
Q4
AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA) for AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA)
Q4
APOTEX CORP. for APOTEX CORP.
Q4
MEHLMAN CONSULTING, INC. for THE CAMPAIGN FOR SUSTAINABLE RX PRICING
3A
FRESENIUS KABI USA LLC for FRESENIUS KABI USA LLC
Q3
AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA) for AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA)
Q3
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
Q3
SANOFI US SERVICES INC. for SANOFI US SERVICES INC
Q3
WHITMER & WORRALL, LLC for CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)
Q3
ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES
Q3
BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
Q3
NOVARTIS for NOVARTIS
Q3
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Q3
MEHLMAN CONSULTING, INC. for ASSOCIATION OF ACCESSIBLE MEDICINES
Q3
FRESENIUS KABI USA LLC for FRESENIUS KABI USA LLC
Q3
MEHLMAN CONSULTING, INC. for THE CAMPAIGN FOR SUSTAINABLE RX PRICING
Q3
APOTEX CORP. for APOTEX CORP.
Q3
FIERCE GOVERNMENT RELATIONS for ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA)
Q3
INTELLECTUAL PROPERTY OWNERS ASSOCIATION for INTELLECTUAL PROPERTY OWNERS ASSOCIATION
Q2
SANOFI US SERVICES INC. for SANOFI US SERVICES INC
Q2
WHITMER & WORRALL, LLC for CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)
Q2
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)